MedPath

ALLOSOURCE

ALLOSOURCE logo
🇺🇸United States
Ownership
Private
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.allosource.org

Clinical Trials

8

Active:2
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

Recruiting
Conditions
Pre-Pectoral Breast Reconstruction Following Mastectomy
First Posted Date
2025-03-03
Last Posted Date
2025-03-04
Lead Sponsor
AlloSource
Target Recruit Count
100
Registration Number
NCT06853964
Locations
🇺🇸

Janiga MDs Plastic Surgery and Cosmetic Center, Reno, Nevada, United States

AlloMend Acellular Dermal Matrix Allograft in Pre-Pectoral Breast Reconstruction

Recruiting
Conditions
Pre-Pectoral Breast Reconstruction Following Single or Double Mastectomy
First Posted Date
2024-07-22
Last Posted Date
2025-01-31
Lead Sponsor
AlloSource
Target Recruit Count
200
Registration Number
NCT06512259
Locations
🇺🇸

Alan H. Chen Surgical Associates, PC, Joliet, Illinois, United States

Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

Not Applicable
Recruiting
Conditions
Osteochondral Defect
First Posted Date
2024-01-22
Last Posted Date
2025-05-18
Lead Sponsor
AlloSource
Target Recruit Count
68
Registration Number
NCT06216756
Locations
🇺🇸

Banner- University Medical Center- Phoenix Orthopedic and Sports Medicine Institute, Phoenix, Arizona, United States

🇺🇸

Cedars-Sinai Kerlan Jobe Institute, Los Angeles, California, United States

🇺🇸

Stanford Medicine-Orthopaedics and Sports Medicine in Redwood City, Redwood City, California, United States

and more 3 locations

Histological Analysis of AlloMend® Acellular Dermal Matrix Used in Breast Implant Surgeries

Active, not recruiting
Conditions
Breast Implant; Complications, Infection or Inflammation
First Posted Date
2023-02-27
Last Posted Date
2025-05-18
Lead Sponsor
AlloSource
Target Recruit Count
30
Registration Number
NCT05744414
Locations
🇺🇸

Janiga MDs Plastic Surgery and Cosmetic Center, Reno, Nevada, United States

Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

Not Applicable
Conditions
Cervical Radiculopathy
Cervical Disc Disorder
Cervical Stenosis
Spondylolisthesis
First Posted Date
2020-12-28
Last Posted Date
2024-08-20
Lead Sponsor
AlloSource
Target Recruit Count
50
Registration Number
NCT04684901
Locations
🇺🇸

Spine Institute of San Diego, San Diego, California, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath